Veronica Mattiello, MD

Johnson&Johnson Innovative Medicine, Italy

Poster(s):

• 1709 - Impact of Dose Intensity of Ibrutinib on Clinical Outcomes of CLL Patients: Analysis of the EVIdeNCE Study